EPS Manager Takehiro Minami On Growing A Japanese CRO Into A Global Provider: An Interview with PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Established in 1991 as a data management company, EPS has become one of the two top-tier contract research organizations in Japan. Founded by Dr. Hao Yan, EPS is now a First Section-listed company on the Tokyo Stock Exchange, and one of only two foreign-established First Section-listed companies in 60 years of TSE history. When the company was founded, Yan was a Chinese graduate student majoring in medical statistics at the University of Tokyo. With more than 2,000 employees, EPS offers major clinical trial services together with software and systems development, and operates in Singapore, Taiwan, South Korea, the Philippines and mainland China.
You may also be interested in...
Japan's EPS Manager Takehiro Minami On What It Takes To Go Global: An Interview with PharmAsia News (Part 2 of 2)
Established in 1991 as a data management company, EPS has become one of the two top-tier contract research organizations in Japan. In part one of this interview, EPS Manager, Office of the President, Takehiro Minami, spoke with PharmAsia News about the company's beginnings and how it has expanded its business in Japan. In this second segment, he discusses the company's business development strategy for emerging markets, as well as in Japan.
Japan's EPS Manager Takehiro Minami On What It Takes To Go Global: An Interview with PharmAsia News (Part 2 of 2)
Established in 1991 as a data management company, EPS has become one of the two top-tier contract research organizations in Japan. In part one of this interview, EPS Manager, Office of the President, Takehiro Minami, spoke with PharmAsia News about the company's beginnings and how it has expanded its business in Japan. In this second segment, he discusses the company's business development strategy for emerging markets, as well as in Japan.
Japan's First CRO CMIC On How ICH Affects Clinical Trials in Japan: An Interview with PharmAsia News (Part 2 of 2)
Established in 1992 as the first contract clinical trial research organization in Japan, CMIC is now one of the largest Japanese CROs and currently employs more than 2,500 employees. The company operates in Japan, the United States, South Korea, Taiwan, Singapore and China. CMIC Corporate Officer Asia Development Moriaki Akasaki sat down with PharmAsia News' Japan bureau to give his perspective on the how the International Conference on Harmonization Good Clinical Practices agreements will affect Japan and other Asian countries. Japan, for the first time is beginning to accept clinical data from China and Koreain accordance with the ICH Regional Harmonization Initiative.